Lipocalin 2 (LCN2) confers acquired resistance to almonertinib in NSCLC through LCN2-MMP-9 signaling pathway
| Autor: | Shi, Chen, Wang, Cong, Fu, Zhiwen, Liu, Jinmei, Zhou, Yuanfeng, Cheng, Bao, Zhang, Cong, Li, Shijun, Zhang, Yu |
|---|---|
| Zdroj: | In Pharmacological Research March 2024 201 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect